Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms

التفاصيل البيبلوغرافية
العنوان:	Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
المؤلفون:	Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Lijuan Chen
المصدر:	Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
بيانات النشر:	Nature Publishing Group, 2024.
سنة النشر:	2024
المجموعة:	LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2044-5385
العلاقة:	https://doaj.org/toc/2044-5385Test
DOI:	10.1038/s41408-024-01058-y
الوصول الحر:	https://doaj.org/article/6aeb2b5162d94e52bba8affde5d0b2f5Test
رقم الانضمام:	edsdoj.6aeb2b5162d94e52bba8affde5d0b2f5
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	20445385
DOI:	10.1038/s41408-024-01058-y